SOdium-glucose CO-transporter inhibition in patients with newly detected Glucose Abnormalities and a recent Myocardial Infarction (SOCOGAMI)

Magnus Lundin,Giulia Ferrannini,Linda Mellbin,Isabelle Johansson,Anna Norhammar,Per Näsman,Bahira Shahim,Stina Smetana,Ashwin Venkateshvaran,Anne Wang,Peder Sörensson,Lars Rydén

Diabetes Research and Clinical Practice（2022）

引用 1|浏览16

暂无评分

摘要

•We randomised coronary patients with dysglycaemia to empagliflozin and placebo.•We investigated their cardiac function with cardiac magnetic resonance.•Empagliflozin did not influence expressions of left ventricular function or dimension.•An explanation may be that left ventricular function was within a normal range.

查看译文

关键词

Dysglycaemia,Acute coronary syndrome,SGLT-2-inhibition,Empagliflozin,Cardiac magnetic resonance tomography,Echocardiography

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要